Economic evaluation of breast cancer screening: A review

Cancer Practice

Volumn 7, Issue 1, 1999, Pages 28-33

  Brown, David W ^a   French, Michael T ^a   Schweitzer, Maurice E ^b   McGeary, Kerry Anne ^b   McCoy, Clyde B ^b   Ullman, Steven G ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Breast cancer; Economic evaluation; Literature review

Indexed keywords

BREAST CANCER; CANCER SCREENING; COST CONTROL; DATA ANALYSIS; ECONOMIC ASPECT; HEALTH CARE COST; MAMMOGRAPHY; MEDICAL LITERATURE; PRACTICE GUIDELINE; QUALITY OF LIFE; RESOURCE ALLOCATION; REVIEW;

AGE DISTRIBUTION; BREAST NEOPLASMS; COST CONTROL; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; FEMALE; HEALTH CARE RATIONING; HUMANS; MASS SCREENING; RISK FACTORS;

EID: 0032898890     PISSN: 10654704     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5394.1999.07103.x     Document Type: Review

References (46)

1. National Cancer Institute. Breast cancer and mammography statistics. Available at: http://rex.nci.nih.gov/MAMMOG_WEB/ MAMMOG_DOC.html and http://rex.nci.nih.gov/ MAMMOG_WEB/MAMMOG_DOC.html. Accessed June 12, 1998.
2. Ries L, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK (eds). SEER Cancer Statistics Review, 1973-1994. National Institutes of Health publication No. 97-2789. Bethesda, Md: National Cancer Institute; 1997.
3. Carter CL, Allen C, Hensen DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181-187.
4. Day NE. Screening for breast cancer. Br Med Bull. 1991;47: 400-415.
5. Schweitzer ME, French MT, Ullmann SG, McCoy CB. Cost-effectiveness of detecting breast cancer in lower socio-economic status African-American and Hispanic women through mobile mammography services. Med Care Res Rev. 1998;55:75-91.
6. Brown ML, Fintor L. The economic burden of cancer. In: Greenwald P, Kramer BS, Weed DL, eds. Cancer Prevention and Control. New York: Marcel Dekker, Inc.; 1994:69-81.
7. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. New York: Oxford University Press; 1997.
8. Udvarhelyi S, Colditz GA, Rai A, Epstein AM. Cost-effectiveness and cost-benefit analysis in the medical literature: are the methods being used correctly? Ann Intern Med. 1992;116: 238-244.
9. Brown ML, Fintor L. Cost effectiveness of breast cancer screening: preliminary results of a systematic review of the literature. Breast Cancer Res Treat. 1993;25:113-118.
10. Gold MR, Russell LB, Siegel JE, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
11. Tolley G, Kenkel D, Fabian R. Valuing Health for Policy: An Economic Approach. Chicago, Ill: The University of Chicago Press; 1994.
12. Johannesson M. Theory and Methods of Economic Evaluation of Health Care. Boston, Mass: Kluwer Academic Publishers; 1996.
13. Moskowitz M, Fox SH. Cost analysis of aggressive breast cancer screening. Radiology. 1979;130:253-256.
14. Sickles EA, Weber WN, Galvin HB, Ominsky SH, Sollitto RA. Mammographic screening: how to operate successfully at low cost. Radiology. 1986;160:95-97.
15. Bird RE. A successful effort to lower costs in screening mammography. Cancer. 1987;60:1684-1687.
16. Moskowitz M. Cost-benefit determinations in screening mammography. Cancer. 1987;60:1680-1683.
17. Moskowitz M. Costs of screening for breast cancer. Radiol Clin North Am. 1987;25:1031-1037.
18. Sickles EA, Weber WN, Galvin HB, Ominsky SH, Sollitto RA. Low-cost mammography screening: practical considerations with emphasis on mobile operation. Cancer. 1987;60: 1688-1691.
19. Eddy DM, Hasselblad V, McGivney W, Hendee W. The value of mammography screening in women under age 50 years. JAMA. 1988;259:1512-1519.
20. Forsyth RA. The mathematics of screening mammography. Med Hypotheses. 1988;26:21-24.
21. Eddy DM. Screening for breast cancer. Ann Intern Med. 1989; 111:389-399.
22. Gerard K, Salkeld G, Hall J. Counting the costs of mammography screening: first year results from the Sydney study. Med J Aust. 1990;152:466-471.
23. Coursen P. On the road: planning and operating a mobile mammography program. Adm Radiol. 1991;10:48-58.
24. de Koning HJ, van Ineveld BM, van Oortmarssen GJ, et al. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer. 1991;49:531-537.
25. Brown ML. Economic considerations in breast cancer screening of older women. J Gerontol. 1992;47:51-58.
26. Zavertnik JJ, McCoy CB, Robinson DS, Love N. Cost-effective management of breast cancer. Cancer. 1992;69(7 suppl): 1979-1984.
27. Janjan NA, Nattinger AB, Young M, Wilson JF. First-year treatment charges for early stage versus locally advanced breast cancer. Breast Dis. 1993;6:27-37.
28. Butler JG, Furnival CM, Hart RFG. Estimating treatment cost functions for progressive diseases: a multiproduct approach with an application to breast cancer. J Health Econ. 1995;14: 361-385.
29. Butler JG, Furnival CM, Hart RFG. The costs of treating breast cancer in Australia and the implications for breast cancer screening. Aust N Z J Surg. 1995;65:485-491.
30. Kattlove H, Liberati A, Keeler E, Brook RH. Benefits and costs of screening and treatment for early breast cancer. JAMA. 1995;273:142-148.
31. Riley GF, Potosky AL, Lubitz JD, Kessler LG. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care. 1995;33:828-841.
32. Legoretta AP, Brooks RJ, Leibowitz AN, Solin LJ. Cost of breast cancer treatment: a 4 year longitudinal study. Arch Intern Med. 1996;156:2197-2201.
33. Mandelblatt J, Freeman H, Winczewski D, et al. The costs and effects of cervical and breast cancer screening in a public hospital emergency room. Am J Public Health. 1997;87: 1182-1189.
34. Fireman BH, Quesenberry CP, Somkin CP, et al. Cost of care for cancer in a health maintenance organization. Health Care Financing Review. 1997;18:51-76.
35. Krahn M, Naglie G. Principles of economic evaluation in cancer screening. Cancer Treat Res. 1996;86:25-40.
36. Goddard M, Hutton J. Economic evaluation of trends in cancer therapy: marginal or average costs? Int J Technol Assess Health Care. 1991;7:594-603.
37. Hayman J, Weeks J, Mauch P. Economic analyses in health care: an introduction to the methodology with an emphasis on radiation therapy. Int J Radiat Oncol Biol Phys. 1996;35: 827-841.
38. Hillner BE. Economic and cost-effectiveness issues in breast cancer treatment. Semin Oncol. 1996;23(suppl 2):98-104.
39. Brown ML. Sensitivity analysis in the cost-effectiveness of breast cancer screening. Cancer. 1992;69:1963-1967.
40. Mushlin AI, Fintor L. Is screening for breast cancer cost-effective? Cancer. 1992;69:1957-1962.
41. Bureau of Labor Statistics, Department of Labor. Medical Care Services Consumer Price Index, 1998. Washington, DC: Government Printing Office; 1998.
42. Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96:102-109.
43. Wolff N, Helminiak TW, Tebes JK. Getting the cost right in cost-effectiveness analyses. Am J Psychiatry. 1997;154: 736-743.
44. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. JAMA. 1996;276:1172-1177.
45. Tolley G, Kenkel D, Fabian R, Webster D. The use of health values in policy. In: Tolley G, Kenkel D, Fabian R, eds. Valuing Health for Policy: An Economic Approach. Chicago, Ill: The University of Chicago Press; 1994.
46. Cyrlak D. Induced costs of low-cost screening mammography. Radiology. 1988;168:661-663.